Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 10;15(3):908.
doi: 10.3390/pharmaceutics15030908.

Current Evidence on Bisphenol A Exposure and the Molecular Mechanism Involved in Related Pathological Conditions

Affiliations
Review

Current Evidence on Bisphenol A Exposure and the Molecular Mechanism Involved in Related Pathological Conditions

Ylenia Della Rocca et al. Pharmaceutics. .

Abstract

Bisphenol A (BPA) is one of the so-called endocrine disrupting chemicals (EDCs) and is thought to be involved in the pathogenesis of different morbid conditions: immune-mediated disorders, type-2 diabetes mellitus, cardiovascular diseases, and cancer. The purpose of this review is to analyze the mechanism of action of bisphenol A, with a special focus on mesenchymal stromal/stem cells (MSCs) and adipogenesis. Its uses will be assessed in various fields: dental, orthopedic, and industrial. The different pathological or physiological conditions altered by BPA and the related molecular pathways will be taken into consideration.

Keywords: bisphenol A; endocrine disruptors; mesenchymal stem cells.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Potential BPA origin. BPA exposure sources involve ingestion, maternofetal transmission, inhalation, skin, and eye contact. (Created with BioRender.com).
Figure 2
Figure 2
The adverse effects of bisphenol A on human health. BPA can negatively impact different targets once introduced into the human body, such as thyroid, heart, reproductive apparatus, gut, immune system, and kidneys (created with BioRender.com).
Figure 3
Figure 3
Schematic representation of the main targets for BPA in the human body, including MSCs (mesenchymal stem cells). Created with BioRender.com.

References

    1. Wan M.L.Y., Co V.A., El-Nezami H. Endocrine disrupting chemicals and breast cancer: A systematic review of epidemiological studies. Crit. Rev. Food Sci. 2022;62:6549–6576. doi: 10.1080/10408398.2021.1903382. - DOI - PubMed
    1. Diamanti-Kandarakis E., Bourguignon J.P., Giudice L.C., Hauser R., Prins G.S., Soto A.M., Zoeller R.T., Gore A.C. Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement. Endocr. Rev. 2009;30:293–342. doi: 10.1210/er.2009-0002. - DOI - PMC - PubMed
    1. Mendes J.J.A. The endocrine disrupters: A major medical challenge. Food Chem. Toxicol. 2002;40:781–788. doi: 10.1016/S0278-6915(02)00018-2. - DOI - PubMed
    1. Monneret C. What is an endocrine disruptor? Comptes Rendus Biol. 2017;340:403–405. doi: 10.1016/j.crvi.2017.07.004. - DOI - PubMed
    1. Cargnelutti F., Di Nisio A., Pallotti F., Sabovic I., Spaziani M., Tarsitano M.G., Paoli D., Foresta C. Effects of endocrine disruptors on fetal testis development, male puberty, and transition age. Endocrine. 2021;72:591–595. doi: 10.1007/s12020-020-02581-1. - DOI - PMC - PubMed

LinkOut - more resources